Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 1/20 | 0.63 |
| ▸ | LPAR1 | Q92633 | 9/20 | 0.62 |
| ▸ | LPAR3 | Q9UBY5 | 9/20 | 0.62 |
| ▸ | LPAR2 | Q9HBW0 | 4/20 | 0.62 |
| ▸ | LPAR6 | P43657 | 3/20 | 0.62 |
| ▸ | LPAR4 | Q99677 | 3/20 | 0.62 |
| ▸ | LPAR5 | Q9H1C0 | 3/20 | 0.62 |
| ▸ | PRKD3 | O94806 | 2/20 | 0.59 |
| ▸ | PRKCG | P05129 | 2/20 | 0.59 |
| ▸ | PRKCB | P05771 | 2/20 | 0.59 |
| ▸ | PRKCA | P17252 | 2/20 | 0.59 |
| ▸ | PRKCH | P24723 | 2/20 | 0.59 |
| ▸ | PRKCI | P41743 | 2/20 | 0.59 |
| ▸ | PRKCE | Q02156 | 2/20 | 0.59 |
| ▸ | PRKCQ | Q04759 | 2/20 | 0.59 |
| ▸ | PRKCZ | Q05513 | 2/20 | 0.59 |
| ▸ | PRKCD | Q05655 | 2/20 | 0.59 |
| ▸ | PRKD1 | Q15139 | 2/20 | 0.59 |
| ▸ | HTT | P42858 | 2/20 | 0.52 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6687853 | 1.00 | USP2 (0.63) | USP2LPAR1LPAR3LPAR2LPAR6 | |
| SCHEMBL10933257 | 1.00 | USP2 (0.63) | USP2LPAR1LPAR3LPAR2LPAR6 | |
| SCHEMBL10949767 | 1.00 | USP2 (0.63) | USP2LPAR1LPAR3LPAR2LPAR6 | |
| SCHEMBL2671655 | 1.00 | USP2 (0.63) | USP2LPAR1LPAR3LPAR2LPAR6 | |
| SCHEMBL10566104 | 1.00 | USP2 (0.63) | USP2LPAR1LPAR3LPAR2LPAR6 | |
| SCHEMBL10959285 | 1.00 | USP2 (0.63) | USP2LPAR1LPAR3LPAR2LPAR6 | |
| SCHEMBL10549855 | 1.00 | USP2 (0.63) | USP2LPAR1LPAR3LPAR2LPAR6 | |
| SCHEMBL5796672 | 1.00 | USP2 (0.63) | USP2LPAR1LPAR3LPAR2LPAR6 | |
| SCHEMBL10204069 | 1.00 | USP2 (0.63) | USP2LPAR1LPAR3LPAR2LPAR6 | |
| SCHEMBL10565936 | 1.00 | USP2 (0.63) | USP2LPAR1LPAR3LPAR2LPAR6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 70 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100086583-A1 | LIPID-ANALOGOUS PHOSPHORIC TRIESTERS | MAX-PLANCK-GESELLSCHAFT ZUR FOERDERUNG DER WISSENSCHAFTEN E.V. (DE) | 2010-04-08 | — | — | US | claimed |
| US-7592469-B2 | Lipid-analogous phosphoric acid triesters | MAX-PLANCK-GESELLSCHAFT ZUR FOERDERUNG DER WISSENSCHAFTEN E.V. (DE) | 2009-09-22 | — | — | US | claimed |
| EP-1556391-B1 | LIPID-ANALOG PHOSPHORIC ACID TRIESTER | MAX PLANCK GESELLSCHAFT (DE) | 2007-08-01 | — | — | EP | claimed |
| US-20060039963-A1 | Lipid-analogo phosphoric acid triesters | MAX-PLANCK-GESELLSCHAFT ZUR FOERDERUNG DER WISSENSCHAFTEN E.V. (DE) | 2006-02-23 | — | — | US | claimed |
| US-20230295201-A1 | ANTIVIRAL COMPOUNDS | GILEAD SCIENCES, INC. | 2023-09-21 | — | — | US | disclosed |
| US-20230295201-A1 | ANTIVIRAL COMPOUNDS | GILEAD SCIENCES, INC. | 2023-09-21 | — | — | US | disclosed |
| CN-112521518-B | Modified starch and preparation method and application thereof | 瑞辰星生物技术（广州）有限公司 | 2023-04-07 | — | — | CN | disclosed |
| CN-112520831-B | Method for recovering free starch in papermaking white water | 瑞辰星生物技术（广州）有限公司 | 2023-03-14 | — | — | CN | disclosed |
| CN-110476063-B | Hydrophilized colored cellulose fine particles | 旭化成株式会社 | 2022-11-15 | — | — | CN | disclosed |
| CN-115175735-A | Antiviral compounds | 吉利德科学公司 | 2022-10-11 | — | — | CN | disclosed |
| CN-112522989-B | Method for making paper | 瑞辰星生物技术（广州）有限公司 | 2022-07-29 | — | — | CN | disclosed |
| US-10071110-B2 | Phosphonate compounds | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2018-09-11 | — | — | US | disclosed |
| US-5057530-A | For inhibiting blood platelet activating faactors | HOFFMANN-LA ROCHE INC. (US) | 1991-10-15 | — | — | US | disclosed |
| US-4863941-A | PLATELET ACTIVATING FACTOR INHIBITORS, ANTITUMOR AGENTS | HOFFMANN-LA ROCHE INC. (US) | 1989-09-05 | — | — | US | disclosed |
| US-4804789-A | D-mannite derivatives as starting products for the synthesis of phospholipids | MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN E.V. (DE) | 1989-02-14 | — | — | US | disclosed |
| EP-0147768-B1 | GLYCERIN DERIVATIVES | F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) | 1989-02-08 | — | — | EP | disclosed |
| US-4739095-A | Derivatives of N,N-(2-chloro-ethyl)-phosphoric acid amide | MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN E.V. (DE) | 1988-04-19 | — | — | US | disclosed |
| US-4734225-A | ANTITUMOR AGENTS | MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN E.V. (DE) | 1988-03-29 | — | — | US | disclosed |
| US-4731373-A | BLOOD PLATELET ACTIVATING FACTOR | HOFFMAN-LA ROCHE INC. (US) | 1988-03-15 | — | — | US | disclosed |
| EP-0208932-A2 | Glycerin derivatives | F. HOFFMANN-LA ROCHE AG (CH) | 1987-01-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230295201-A1 | ANTIVIRAL COMPOUNDS | MAVS, HAVCR2, ZC3HAV1 | USP2 4095/4885LPAR1 1068/4885LPAR3 1521/4885 |
| US-10071110-B2 | Phosphonate compounds | PHPT1, PHOSPHO1, PIK3CA | USP2 4514/4885LPAR1 1088/4885LPAR3 1074/4885 |
| US-20060039963-A1 | Lipid-analogo phosphoric acid triesters | PHOSPHO1, LIPC, LIPA | USP2 3905/4885LPAR1 22/4885LPAR3 45/4885 |
| US-20100086583-A1 | LIPID-ANALOGOUS PHOSPHORIC TRIESTERS | PHOSPHO1, LIPC, LIPA | USP2 2903/4885LPAR1 41/4885LPAR3 47/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.